Post Traumatic Stress Disorder: Clinical Trials

412 trials for Post Traumatic Stress Disorder, newest first
ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

200 completed, 70 recruiting, 65 unknown, 19 terminated. 245 Not applicable, 57 Phase 2, 22 Phase 1, 16 Phase 3, 9 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable245Completed 126, Recruiting 43, Unknown 36, Withdrawn 12, Active not recruiting 10, Terminated 8, Not yet recruiting 6, Enrolling by invitation 3, Suspended 1
Phase 257Completed 18, Recruiting 16, Terminated 6, Suspended 5, Unknown 5, Not yet recruiting 3, Active not recruiting 2, Withdrawn 2
Phase 122Completed 11, Not yet recruiting 2, Recruiting 2, Terminated 2, Unknown 2, Withdrawn 2, Active not recruiting 1
Phase 316Recruiting 6, Completed 5, Unknown 2, Active not recruiting 1, Enrolling by invitation 1, Withdrawn 1
Phase 49Completed 7, Active not recruiting 1, Terminated 1
Early Phase 13Completed 2, Terminated 1

Follow Post Traumatic Stress Disorder: new trials by email Literature Review of Post Traumatic Stress Disorder trials Research Report on Post Traumatic Stress Disorder

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Department of Defense PTSD Adaptive Platform Trial - Intervention D - SLS-002
Intervention D SLS-002, Intervention D Placebo - Post Traumatic Stress Disorder		Phase 2SuspendedGlobal Coalition for Adaptive Research2002028-05-012026-05-20
Department of Defense PTSD Adaptive Platform Trial - Intervention B - Vilazodone
Intervention B Vilazodone Hydrochloride (HCl), Intervention B Placebo - Post Traumatic Stress Disorder		Phase 2Not yet recruitingGlobal Coalition for Adaptive Research2002027-08-012026-05-20
Identification of Physiological Sleep Indices That Reflect Clinical Improvement and Reduction in Stress Biomarkers After Stellate Ganglion Block in Patients With Posttraumatic Stress Disorder (PTSD)
Stellate ganglion block - Post Traumatic Stress Disorder		Not applicableNot yet recruitingsara dichtwald602027-08-012026-10-07
Cognitive Processing Therapy for Posttraumatic Stress Disorder and Co-occurring Lived Experience Stress
Standard CPT, CPT-LEAP - Post Traumatic Stress Disorder		Not applicableNot yet recruitingBoston University522027-01-012026-09-30
Clinical Trial of MDMA-Assisted Therapy for Military Service Members With Posttraumatic Stress Disorder
TREATMENT ARM: Full dose, CONTROL ARM: Active-controlled - PTSD, Post Traumatic Stress Disorder PTSD		Phase 2Not yet recruitingU.S. Army Medical Research and Development Command862026-10-012026-07-15
Noninvasive Brain Stimulation Combined With Written Exposure Therapy for PTSD in Military Personnel With TBI
Transcranial Direct Current Stimulator, Written Exposure Therapy - Post Traumatic Stress Disorder		Not applicableNot yet recruitingThe University of Texas Health Science Center at San Antonio1502026-09-302026-07-20
Effects of Stimulant Medications in PTSD
Placebo, Adderall - Adderall, PTSD		Phase 1Not yet recruitingUniversity of Chicago402026-09-152026-06-24
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD
TSND-201, Placebo - Post Traumatic Stress Disorder		Phase 3RecruitingTranscend Therapeutics3002026-09-012026-09-23
Wayne State Warriors Marijuana Clinical Research Program: Cannabinoid Adjunct to Prolonged Exposure & Recovery
Cannabidiol (CBD) only, Placebo only, Delta-9-tetrahydrocannabinol (THC) only - PTSD, Post Traumatic Stress Disorder		Phase 1 / Phase 2Not yet recruitingLeslie Lundahl2802026-09-012026-08-26
Mindfulness-based Psilocybin Therapy for PTSD
Psilocybin + MBCT therapy, Active Comparator: Psilocybin with Support Only - Post Traumatic Stress Disorder, Depression - Major Depressive Disorder		Phase 2RecruitingAnthony P King302026-09-012026-10-19
Brief SEE FAR CBT Intervention Compared With Treatment as Usual for Adults With PTSD
Brief SEE FAR CBT Intervention, Dynamic Psychotherapy Treatment as Usual - Post Traumatic Stress Disorder		Not applicableRecruitingCommunity Stress Prevention Center602026-07-012026-07-17
MDMA-Assisted Massed Exposure Therapy for PTSD
3,4-Methylenedioxymethamphetamine (MDMA), Placebo, Massed Prolonged Exposure (PE) - Post Traumatic Stress Disorder		Phase 2RecruitingEmory University2002026-07-012026-05-26
SEE FAR CBT Intervention for Adults With PTSD
SEE FAR CBT - Post Traumatic Stress Disorder		Not applicableRecruitingCommunity Stress Prevention Center602026-07-012026-07-22
MDMA Therapy in Veterans With PTSD
MDMA - Post Traumatic Stress Disorder		Phase 2RecruitingSunstone Medical522026-06-302026-07-01
An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSD
TSND-201 - Post Traumatic Stress Disorder		Phase 3Enrolling by invitationTranscend Therapeutics3002026-06-222026-09-04
Psilocybin-Assisted Cognitive Processing Therapy for Chronic PTSD
Psilocybin - Post Traumatic Stress Disorder, PTSD		Phase 2Active not recruitingUnity Health Toronto152026-06-012026-10-06
Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD
Psilocybin 25 mg - Post Traumatic Stress Disorder, PTSD		Phase 2RecruitingSunstone Medical702026-05-232026-07-01
MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use Disorder
Full Dose MDMA, MDMA-Assisted psychotherapy, Active Placebo Dose MDMA - Post Traumatic Stress Disorder, Alcohol Use Disorder		Phase 2 / Phase 3RecruitingVA Office of Research and Development802026-05-182026-06-02
Predictive Value of Early Peritraumatic Distress Screening for Childbirth-PTSD Following Unplanned Cesarean Delivery
Postpartum Psychological Screening - Post Traumatic Stress Disorder, Post Partum Depression		RecruitingUniversity of British Columbia4202026-05-082026-05-19
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
TSND-201, Placebo - Post Traumatic Stress Disorder		Phase 3RecruitingTranscend Therapeutics3002026-04-022026-09-17

Showing 20 of 412. Sign in to see all of them.

Narrower conditions

Stress Disorders, Post-Traumatic (412)  ·  Depression (69)  ·  Anxiety Disorders (65)  ·  Wounds and Injuries (21)  ·  COVID-19 (18)  ·  Depressive Disorder, Major (18)  ·  Alcoholism (17)  ·  Brain Injuries, Traumatic (16)  ·  Psychological Well-Being (16)  ·  Substance-Related Disorders (15)  ·  Mental Disorders (12)  ·  Suicide (10)  ·  Bipolar Disorder (9)  ·  Depressive Disorder (8)  ·  Stress, Psychological (8)

Broader conditions

Stress Disorders, Traumatic (405)  ·  Trauma and Stressor Related Disorders (405)  ·  Mental Disorders (400)  ·  Behavior (113)  ·  Behavioral Symptoms (90)  ·  Nervous System Diseases (45)  ·  Chemically-Induced Disorders (37)  ·  Mood Disorders (30)  ·  Pathological Conditions, Signs and Symptoms (29)  ·  Central Nervous System Diseases (25)  ·  Wounds and Injuries (25)  ·  Brain Diseases (24)  ·  Craniocerebral Trauma (22)  ·  Substance-Related Disorders (22)  ·  Trauma, Nervous System (22)

Interventions

Therapeutics (15)  ·  Ketamine (9)  ·  N-Methyl-3,4-methylenedioxyamphetamine (9)  ·  Psilocybin (7)  ·  Transcranial Magnetic Stimulation (7)  ·  methylone (6)  ·  Cannabidiol (5)  ·  Eye Movement Desensitization Reprocessing (5)  ·  Methods (4)  ·  Psychotherapy (4)  ·  Sertraline (4)  ·  Surveys and Questionnaires (4)  ·  Transcranial Direct Current Stimulation (4)  ·  Waiting Lists (4)  ·  2-cyclohexylidenhydrazo-4-phenyl-thiazole (3)

Sponsors

VA Office of Research and Development (18)  ·  Karolinska Institutet (13)  ·  Yale University (9)  ·  Transcend Therapeutics (7)  ·  Hospices Civils de Lyon (6)  ·  Emory University (5)  ·  Global Coalition for Adaptive Research (5)  ·  NYU Langone Health (5)  ·  University of Texas at Austin (5)  ·  Wayne State University (5)  ·  Duke University (4)  ·  Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital (4)  ·  Sheba Medical Center (4)  ·  The University of Texas Health Science Center at San Antonio (4)  ·  University of Washington (4)

Countries

United States (231)  ·  France (32)  ·  Canada (27)  ·  Israel (20)  ·  Sweden (14)  ·  United Kingdom (13)  ·  Norway (10)  ·  Denmark (8)  ·  Italy (5)  ·  Germany (4)  ·  Switzerland (4)  ·  Turkey (Türkiye) (4)  ·  Australia (3)  ·  Brazil (3)  ·  Chile (2)

Top investigators

Anne Wagner, PhD (2)  ·  Asle Hoffart, PhD (2)  ·  Casey Straud, PsyD (2)  ·  Charles Marmar, MD (2)  ·  Emily Holmes, Prof (2)  ·  Erik Andersson, PhD (2)  ·  John Krystal, MD (2)  ·  Laura Meis, PhD (2)  ·  Lauren C Ng, PhD (2)  ·  Meital Mashash, PhD (2)  ·  Ronald Acierno, PhD (2)  ·  Sandra E Moll, PhD (2)  ·  Sarah Valentine, PhD (2)  ·  Shannon Dorsey, PhD (2)

Results publications

PMID 35141873, PMID 38767196, PMID 12482187, PMID 19406860, PMID 21169860, PMID 21515904, PMID 21741804, PMID 21961947, PMID 22026588, PMID 22362158, PMID 22884217, PMID 22921765, PMID 23076096, PMID 23663588, PMID 23892070, PMID 24199660, PMID 24331545, PMID 25904871, PMID 25935315, PMID 26111066, PMID 26432420, PMID 26717906, PMID 26797658, PMID 27825327, PMID 27863313, PMID 27898154, PMID 28264720, PMID 28277702, PMID 29110681, PMID 29163311, PMID 29533154, PMID 29717652, PMID 30465479, PMID 30514434, PMID 30541492, PMID 30732844, PMID 30824252, PMID 31125845, PMID 31125916, PMID 31146712, PMID 31407212, PMID 31653228, PMID 31669451, PMID 31708812, PMID 31914959, PMID 31920733, PMID 31968059, PMID 32066475, PMID 32609959, PMID 32617173

NIH funding

2023 (3), 2019 (2), R01MH122867 (2), R44MH136888 (2), 1IK2CX002101-01A2 (1), 2017 (1), 3UF1MH121954-01S1 (1), F32AT006092 (1), I01CX002760 (1), I01RX003140 (1), I01RX003623 (1), I21RX001432 (1), K01MH121653 (1), K23AT009713 (1), K23MD018433 (1)